ArticleZeitschrift fur Geburtshilfe und Neonatologie2026
Management of Amniotic Fluid Embolism (AFE) using anticoagulation-free ECMO.
Article in Zeitschrift fur Geburtshilfe und Neonatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Amniotic fluid embolism with liver rupture: a case report.BMC pregnancy and childbirth · 2026Article
- Successful management of amniotic fluid embolism with cardiac arrest and liver rupture: a case report.Frontiers in medicine · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Amniotic fluid embolism (AFE) is a critical obstetric complication characterized by the entry of amniotic fluid and its components into maternal circulation during parturition, leading to acute cardiopulmonary failure, disseminated intravascular coagulation (DIC), and anaphylactic shock. Affected patients typically exhibit abrupt onset, rapid progression, and exceedingly high mortality. Early recognition and prompt intervention are pivotal in AFE management. We present a case of AFE-induced cardiac arrest in a 35-year-old primigravida who developed acute cardiopulmonary collapse during vaginal delivery, followed by cardiac arrest. After cardiopulmonary resuscitation, massive transfusion, and crash emergency cesarean section, anticoagulant-free venoarterial extracorporeal membrane oxygenation (VA-ECMO) was initiated. Subsequent multimodal therapies - including aggressive transfusion support, uterine artery embolization for hemostasis, exploratory laparotomy, and targeted DIC management - ensured safe ECMO maintenance without device-related complications. By hospital day 3, hemodynamic and respiratory stability were achieved, enabling successful ECMO weaning. This case highlights that ECMO remains a viable therapeutic option for salvaging critically ill AFE patients with refractory hemorrhagic shock, DIC, and cardiopulmonary failure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.